Search
for
Sort by
Research 751–780 of 774
- 1,314
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Hair Loss in an 11-year-old
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Androgenetic alopecia – Update 2022
- The Pathobiology of Skin Aging
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Frontal Fibrosing Alopecia: A Review
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- European expert consensus statement on the systemic treatment of alopecia areata
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Medical Dermatology
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Three Types of Alopecia in One Patient: A Case of Central Centrifugal Cicatricial Alopecia, Alopecia Areata, and Telogen Effluvium
- Update From Dermatology Nurses’ Association Convention 2025
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Hair Disorders in Autoimmune Diseases
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata